ニューロトロフィク因子分泌の誘発体である (+) -コンプランアジンAの合成
Changxia Yuan1, Chih-Tsung Chang, Abram Axelrod
1Department of Chemistry and Biochemistry, The University of Texas at Austin, Austin, Texas 78712, USA.
Journal of the American Chemical Society
|April 15, 2010
まとめ
研究者らは,ライコポディアムのアルカロイド (+) -コンプランアジンAの全合成を達成しました. この天然製品は,神経栄養因子の分泌を誘導することによって,神経細胞の分化を促進します.
科学分野:
- 有機化学 オーガニック・ケミストリー
- 神経科学は神経科学である.
- 自然製品合成 自然製品合成
背景:
- ライコポディアムアルカロイドは,多様な生物学的活動を持つ複雑な自然製品のクラスです.
- コンプラナジンAは,神経の分化を促進する可能性を実証しています.
- 複雑なアルカロイドへの効率的な合成経路は,さらなる生物学的調査に不可欠です.
研究 の 目的:
- ライコポディアム・アルカロイド (+) - コンプランアジンAの新しく効率的な全合成について説明する.
- このニューロトロフィク因子誘発化合物にアクセスするためのスケーラブルな経路を提供するために.
- 天然製品合成における金属媒介サイクロアディション反応の有用性を調査する.
主な方法:
- 金属媒介の連続 [2+2+2] + [2+2+2] のサイクル添加戦略が採用されました.
- 合成には,シリル置換ダイネとアルキン-ニトリルを使用した.
- このアプローチは,複雑なアルカロイド核の迅速な構築を容易にした.
主要な成果:
- (+) -コンプランアジンAの全合成が成功しました.
- 合成経路は,ターゲット天然製品への迅速なアクセスを提供しました.
- 方法論は,採用されたサイクル添加配列の効率性を強調しています.
結論:
- 開発された合成戦略は, (+) -コンプラナジンA.A.への効率的な経路を提供します.
- この合成により,コンプラナジンAの神経栄養特性に関するさらなる研究が可能になった.
- 金属媒介のサイクル添加は,複雑なアルカロイド構造を構築するための強力なツールです.
関連する概念動画
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...